Ascend Clinical Research Limited
15532027
Some Concerns
- Negative net worth (-10)
- 2 outstanding charges (-4)
Details
Compliance
Last accounts
28/02/2025
micro entity
Next accounts due
30/11/2026
Confirmation statement
Last: 05/12/2025
Due 19/12/2026
Industry
Officers
director · Since 29/02/2024
COMPANY DIRECTOR
FILIPINO · ENGLAND · Age 37
director · Since 10/12/2024
COMPANY DIRECTOR
BRITISH · UNITED KINGDOM · Age 48
secretary · Since 20/05/2025
Persons with Significant Control
Mrs Ma Cara Veronica Estella Caasi
Filipino · England · Age 37
4b Vulcan House, Calleva Park, Aldermaston, Calleva Park, Reading, RG7 8PA
Notified 29/02/2024
Miss Alexandra Marie Diaz
British · United Kingdom · Age 48
33 Teeswater Close, Long Lawford, Rygby, Teeswater Close, Rugby, CV23 9GA
Notified 02/09/2025
Charges2 outstanding
NATIONWIDE FINANCE LIMITED
NATIONWIDE FINANCE LTD
CompanyRankvs 74646+ SIC 86900 peers12
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Outstanding charges: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 28/02/2026
Net Worth
-£154k
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
-£113k
Working capital
Current Assets
£13k
Current Liabilities
£126k
Fixed Assets
£48k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2026 | 0.10 | -£150k |
| 2025 | 0.00 | — |
Derived from filed accounts. Not audited figures.